Who owns Electra Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ETRA from SEC Form 13F filings across 59 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 59 institutions disclosed 50.7M shares of Electra Therapeutics, Inc. worth $570.9M — about 736.4% of shares outstanding; the largest disclosed holder is ORBIMED ADVISORS LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
59
13F holders
$570.9M
value, 2026 filers
736.4%
of shares outstanding (50.7M sh)
59
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ETRA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLCNEW | 6.9M | $77.5M | 1.4% | 99.9% | new |
| 2 | Redmile Group, LLCNEW | 5.4M | $61.1M | 4.5% | 78.8% | new |
| 3 | EQT Fund Management S.a r.l.NEW | 3.8M | $42.7M | 4.5% | 55.1% | new |
| 4 | Cormorant Asset Management, LPNEW | 3.4M | $37.9M | 2.5% | 48.8% | new |
| 5 | Nextech Invest Ltd.NEW | 2.6M | $29.7M | 1.3% | 38.3% | new |
| 6 | Blue Owl Capital Holdings LPNEW | 2.6M | $29.4M | 5.4% | 37.9% | new |
| 7 | SanofiNEW | 2.5M | $27.7M | 4.4% | 35.7% | new |
| 8 | Jefferies Financial Group Inc.NEW | 2.2M | $25.2M | 0.2% | 32.6% | new |
| 9 | JPMORGAN CHASE & CONEW | 2.1M | $23.8M | 0.0% | 30.4% | new |
| 10 | MIC Capital Management UK LLPNEW | 2.0M | $22.2M | 4.8% | 28.7% | new |
| 11 | EcoR1 Capital, LLCNEW | 1.7M | $19.1M | 0.8% | 24.7% | new |
| 12 | FARALLON CAPITAL MANAGEMENT, L.L.C.NEW | 1.7M | $19.1M | 0.1% | 24.7% | new |
| 13 | RA CAPITAL MANAGEMENT, L.P.NEW | 1.7M | $19.0M | 0.2% | 24.6% | new |
| 14 | ALLIANCEBERNSTEIN L.P.NEW | 1.5M | $17.1M | 0.0% | 22.1% | new |
| 15 | Balyasny Asset Management L.P.NEW | 1.2M | $13.4M | 0.0% | 17.3% | new |
| 16 | Hood River Capital Management LLCNEW | 1.1M | $12.5M | 0.1% | 16.1% | new |
| 17 | Logos Global Management LPNEW | 1.0M | $11.3M | 0.6% | 14.5% | new |
| 18 | JENNISON ASSOCIATES LLCNEW | 923,036 | $10.4M | 0.0% | 13.4% | new |
| 19 | BRAIDWELL LPNEW | 905,731 | $10.2M | 0.4% | 13.1% | new |
| 20 | T. Rowe Price Investment Management, Inc.NEW | 710,981 | $8.0M | 0.0% | 10.3% | new |
| 21 | DEERFIELD MANAGEMENT COMPANY, L.P.NEW | 700,000 | $7.9M | 0.1% | 10.2% | new |
| 22 | SEVEN GRAND MANAGERS, LLCNEW | 540,303 | $6.1M | 0.2% | 7.8% | new |
| 23 | Boxer Capital Management, LLCNEW | 450,000 | $5.1M | 0.4% | 6.5% | new |
| 24 | MILLENNIUM MANAGEMENT LLCNEW | 368,373 | $4.1M | 0.0% | 5.3% | new |
| 25 | Woodline Partners LPNEW | 360,775 | $4.1M | 0.0% | 5.2% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.